Effectiveness of fluconazole in murine Candida albicans and bacterial C. albicans peritonitis and abscess formation

References

• Marina NM, Flynn PM, Rivera GK, Hughes WT. Candida tropicalis and Candida albicans fungemia in children with leukemia. Cancer 1991; 68: 594–599
   PubMed Web of Science ®Google Scholar
• Marshall JC, Christou NV, Horn R, Meakins JL. The microbiology of multiple organ failure. The proximal gastrointestinal tract as an occult reservoir of pathogens. Arch Surg 1988; 123: 309–315
   PubMedGoogle Scholar
• Sawyer RG, Rosenlof LK, Adams RB, May AK, Spengler MD, Pruett TL. Peritonitis into the 1990's: changing pathogens and changing strategies in the critically ill. Am Surg 1992; 58: 82–87
   PubMed Web of Science ®Google Scholar
• Solomkin JS, Flohr A, Simmons RL. Candida infections in surgical patients. Dose requirements and toxicity of amphotericin B. Ann Surg 1982; 195: 177–185
   PubMed Web of Science ®Google Scholar
• Vaudry WL, Tierney AJ, Wenman WM. Investigation of a cluster of Candida albicans infections in a neonatal intensive care unit. J Infect Dis 1988; 158: 1375–1379
   PubMed Web of Science ®Google Scholar
• Whelan WL, Kirsch DR, Kwon-Chung KJ, Wahl SM, Smith PD. Candida albicans in patients with the acquired immunodeficiency syndrome: absence of a novel hypervirulent strain. J Infect Dis 1990; 162: 513–518
   PubMed Web of Science ®Google Scholar
• Galgiani JM. Fluconazole, a new antifungal agent. Ann Intern Med 1990; 113: 177–179
   PubMed Web of Science ®Google Scholar
• Grant SM, Clissold SP. Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs 1990; 39: 877–916
   PubMed Web of Science ®Google Scholar
• Saag MS, Dismukes WE. Azole antifungal agents: emphasis on new triazoles. Antimicrob Agents Chemother 1988; 32: 1–8
   PubMed Web of Science ®Google Scholar
• Sugar AM. Fluconazole and itraconazole: Current status and prospects for antifungal therapy. Curr Clin Topics Infect Dis 1993; 13: 74–98
   PubMedGoogle Scholar
• Rogers TE, Galgiani JN. Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother 1986; 30: 4318–4322
   Web of Science ®Google Scholar
• Kujath P, Lerch K. Secondary mycosis in surgery: treatment with fluconazole. Infection 1989; 17: 111–117
   PubMed Web of Science ®Google Scholar
• Kujath P, Lerch K, Kochendorfer P, Boos C. Comparative study of the efficacy of fluconazole versus amphotericin B/flucytosine in surgical patients with systemic mycoses. Infection 1993; 21: 376–382
   PubMed Web of Science ®Google Scholar
• Nolla-Salas J, Leon C, Torres-Rodriguez JM, Martin E, Sitges-Serra A. Treatment of candidemia in critically ill surgical patients with intravenous fluconazole. Clin Infect Dis 1992; 14: 952–954
   PubMed Web of Science ®Google Scholar
• Viviani, MA, Tortorano, AM, Pagano, A, et al. Il fluconazolo nel trattamento della candidosi profonda nei pazienti chirurgici. G Italiano Chemioter 1988; 35: 57–60
   PubMedGoogle Scholar
• Sawyer RG, Adams RB, May AK, Rosenlof LK, Pruett TL. Development of Candida albicans and C. albicans/Escherichia coli/Bacteroides fragilis intraperitoneal abscess models with demonstration of fungus-induced bacterial translocation. J Med Vet Mycol 1995; 33: 49–52
   PubMedGoogle Scholar
• Sawyer RG, Adams RB, May AK, Rosenlof LK, Pruett TL. Anti-tumor necrosis factor antibody reduces mortality in the presence of antibiotic-induced tumor necrosis factor release. Arch Surg 1993; 128: 73–77
   PubMed Web of Science ®Google Scholar
• Galis HA, Drew RH, Pickard WW. Amphotericin B: 30 years of clinical experience. Rev Infect Dis 1990; 12: 308–329
   PubMedGoogle Scholar
• Filler SG, Crislip MA, Mayer CL, Edwards JE. Comparison of fluconazole and amphotericin B for treatment of disseminated candidiasis and endophthalmitis in rabbits. Antimicrob Agents Chemother 1991; 35: 288–292
   PubMed Web of Science ®Google Scholar
• Jafari, HS, Saez-Llorens, X, Severien, C, et al. Effects of antifungal therapy on inflammation, sterilization, and histology in experimental Candida albicans meningitis. Antimicrob Agents Chemother 1994; 38: 83–89
   PubMed Web of Science ®Google Scholar
• Van't Wout JW, Mattie H, van Furth R. Comparison of the efficacies of amphotericin B, fluconazole and itraconazole against systemic Candida albicans infection in normal and neutropenic mice. Antimicrob Agents Chemother 1989; 33: 147–151
   PubMed Web of Science ®Google Scholar
• Walsh, TJ, Aoki, S, Mechinaud, F, et al. Effects of preventive, early and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated candidiasis. J Infect Dis 1990; 161: 755–760
   PubMed Web of Science ®Google Scholar
• Witt MD, Bayer AS. Comparison of fluconazole and amphotericin B for prevention and treatment of experimental Candida endocarditis. Antimicrob Agents Chemother 1991; 35: 2481–2485
   PubMed Web of Science ®Google Scholar
• Bannatyne RM, Cheng PC, Fong IW. Comparison of the efficacy of cilofungin, fluconazole and amphotericin B in the treatment of systemic Candida albicans infection in the neutropenic mouse. Infection 1992; 20: 168–170
   PubMed Web of Science ®Google Scholar
• Ellis, ME, Clink, H, Ernst, P, et al. Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients. Eur J Clin Microbiol Infect Dis 1994; 13: 3–11
   PubMed Web of Science ®Google Scholar
• Winston, DJ, Chandrasekar, PH, Lazarus, HM, et al. Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial. Ann Intern Med 1993; 118: 495–503
   PubMed Web of Science ®Google Scholar
• Nassoura Z, Ivatury RP, Simon RJ, Jabbour N, Stahl WM. Caniduria as an early marker of disseminated infection in critically ill surgical patients: the role of fluconazole therapy. J Trauma 1993; 35: 290–294
   PubMedGoogle Scholar
• Dupont B, Drouhet E. Fluconazole in the management of oropharyngeal candidosis in a predominantly HIV antibodypositive group of patients. J Med Vet Mycol 1988; 26: 67–71
   PubMedGoogle Scholar
• Phillips RJ, Waton SA, McKay FF. An open multicentre study of the efficacy and safety of a single dose of fluconazole 150 mg in the treatment of vaginal candidiasis in general practice. Br J Clin Pract 1990; 44: 219–222
   PubMedGoogle Scholar
• Bozzette, SA, Larsen, RA, Chiu, J, et al. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. New Engl J Med 1991; 324: 580–584
   PubMed Web of Science ®Google Scholar
• Powderly, WG, Saag, MS, Cloud, GA, et al. A controlled trial of fluconazole or amphotericin B to prevent relapse of crytpococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. New Engl J Med 1992; 326: 793–798
   PubMed Web of Science ®Google Scholar
• Saag, MS, Powderly, WG, Cloud, GA, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. New Engl J Med 1992; 326: 83–89
   PubMed Web of Science ®Google Scholar
• Flannery MT, Simmons DB, Saba H, Altus P, Wallach PM, Adelman HM. Fluconazole in the treatment of hepatosplenic candidiasis. Arch Intern Med 1992; 152: 406–408
   PubMed Web of Science ®Google Scholar
• Anaissie EJH, Darwiche R, Mera J, Gentry L, Abi-Said D, Bodey GP. A prospective randomized multicenter study comparing fluconazole to amphotericin B for nosocomial candidiasis. Program and Abstract of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans. American Society for Microbiology, Washington, DC 1993; 267–267, In abstract 808
   Google Scholar
• Milatovic D, Voss A. Efficacy of fluconazole in the treatment of systemic fungal infections. Eur J Microbiol Infect Dis 1992; 11: 395–402
   PubMed Web of Science ®Google Scholar
• Rex, JH, Bennett, JE, Sugar, AM, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. New Engl J Med 1994; 331: 1325–1330
   PubMed Web of Science ®Google Scholar
• Deitch EA. Bacterial translocation of the gut flora. J Trauma 1990; 30(Suppl. 12)S184–S189
   PubMedGoogle Scholar
• Rotstein OD, Kao J, Houston K. Reciprocal synergy between Escherichia coli and Bacteroides fragilis in an intra-abdominal infection model. J Med Microbiol 1989; 29: 269–276
   PubMed Web of Science ®Google Scholar
• Rotstein OD, Pruett TL, Simmons RL. Lethal microbial synergism in intra-abdominal infections: Escherichia coli and Bacteroides fragilis. Arch Surg 1985; 120: 146–151
   PubMedGoogle Scholar